Octreotide long-acting release (Sandostatin LAR)

octreotide · Novartis

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Octreotide long-acting release (Sandostatin LAR), covering 2015-06-29 to 2015-06-29. Get the full timeline:

Most recent: Clinical Trial Update: Everolimus and LongActing Octreotide Trial in Polycystic Livers [Phase 2]